Literature DB >> 25408354

N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic.

Aditi Banerjee1, Juan A Martinez, Maria O Longas, Zhenbo Zhang, Jesus Santiago, Krishna Baksi, Dipak K Banerjee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25408354      PMCID： PMC4603827          DOI： 10.1007/978-3-319-11280-0_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  49 in total

1.  A holistic approach to protein secondary structure characterization using amide I band Raman spectroscopy.

Authors:  S U Sane; S M Cramer; T M Przybycien
Journal:  Anal Biochem       Date:  1999-05-01       Impact factor: 3.365

Review 2.  Signaling the unfolded protein response from the endoplasmic reticulum.

Authors:  Kezhong Zhang; Randal J Kaufman
Journal:  J Biol Chem       Date:  2004-04-07       Impact factor: 5.157

Review 3.  The control of breast cancer: the role of tamoxifen.

Authors:  J F Forbes
Journal:  Semin Oncol       Date:  1997-02       Impact factor: 4.929

4.  Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Authors:  Chad A Livasy; Gamze Karaca; Rita Nanda; Maria S Tretiakova; Olufunmilayo I Olopade; Dominic T Moore; Charles M Perou
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

Review 5.  Tumoral vascularity as a prognostic factor in cancer.

Authors:  N Weidner; J Folkman
Journal:  Important Adv Oncol       Date:  1996

6.  Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer.

Authors:  M A Rudek; W D Figg; V Dyer; W Dahut; M L Turner; S M Steinberg; D J Liewehr; D R Kohler; J M Pluda; E Reed
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

Review 7.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  Is asparagine-linked protein glycosylation an obligatory requirement for angiogenesis?

Authors:  D K Banerjee; M Vendrell-Ramos
Journal:  Indian J Biochem Biophys       Date:  1993-12       Impact factor: 1.918

10.  Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.

Authors:  Ben Van Calster; Isabelle Vanden Bempt; Maria Drijkoningen; Nathalie Pochet; Jiqiu Cheng; Sabine Van Huffel; Wouter Hendrickx; Julie Decock; Huei-Jean Huang; Karin Leunen; Frederic Amant; Patrick Berteloot; Robert Paridaens; Hans Wildiers; Erik Van Limbergen; Caroline Weltens; Dirk Timmerman; Toon Van Gorp; Ann Smeets; Walter Van den Bogaert; Ignace Vergote; Marie-Rose Christiaens; Patrick Neven
Journal:  Breast Cancer Res Treat       Date:  2008-02-09       Impact factor: 4.872
View more
  6 in total

1.  Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of β-lactams.

Authors:  Neil Pj Price; Trina M Hartman; Jiakun Li; Kiran K Velpula; Todd A Naumann; Maheedhara R Guda; Biao Yu; Kenneth M Bischoff
Journal:  J Antibiot (Tokyo)       Date:  2017-09-27       Impact factor: 2.649

2.  Structure-based drug discovery by targeting N-glycan biosynthesis, dolichyl-phosphate N-acetylglucosaminephosphotransferase.

Authors:  Michio Kurosu
Journal:  Future Med Chem       Date:  2019-03-25       Impact factor: 3.808

3.  Inhibition of N-Glycosylation towards Novel Anti-Cancer Chemotherapeutics.

Authors:  Michio Kurosu
Journal:  J Mol Pharm Org Process Res       Date:  2018-01-12

4.  Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor.

Authors:  Katsuhiko Mitachi; David Mingle; Wendy Effah; Antonio Sánchez-Ruiz; Kirk E Hevener; Ramesh Narayanan; William M Clemons; Francisco Sarabia; Michio Kurosu
Journal:  Angew Chem Int Ed Engl       Date:  2022-06-10       Impact factor: 16.823

5.  Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors.

Authors:  Diluka Peiris; Alexander F Spector; Hannah Lomax-Browne; Tayebeh Azimi; Bala Ramesh; Marilena Loizidou; Hazel Welch; Miriam V Dwek
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

Review 6.  Glycotherapy: A New Paradigm in Breast Cancer Research.

Authors:  Dipak K Banerjee; Arelis Seijo Lebrón; Krishna Baksi
Journal:  Biomolecules       Date:  2022-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.